The effectiveness of preventing premature luteinizing hormone surge by cetrorelix in the controlled ovarian stimulation by letrozole and gonadotropin

Trial Profile

The effectiveness of preventing premature luteinizing hormone surge by cetrorelix in the controlled ovarian stimulation by letrozole and gonadotropin

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Nov 2008

At a glance

  • Drugs Cetrorelix (Primary) ; Follitropin alfa; Letrozole
  • Indications Infertility
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Nov 2008 Status changed from not stated to completed, according to results published in Fertility and Sterility.
    • 02 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top